Analyst firms · Morgan Stanley · BAX

Morgan Stanley BAX price target and rating history

Baxter International Inc. (BAX) · Health Care

Morgan Stanley rates Baxter International Inc. (BAX) Underweight with a $30 price target, as of its latest action on Jul 15, 2024. It has published 6 rating actions on BAX since October 2021, including 1 upgrade and 2 downgrades.

Current rating
Underweight
Price target
$30
Median target, all firms
Too few
Actions on BAX
6

Morgan Stanley price target on BAX

$110$70$3020222023202420252026
Morgan Stanley price target on BAX, each point a stated target, October 2021 to July 2024.

Every Morgan Stanley rating on BAX

How other firms rate BAX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wolfe ResearchPeer PerformOct 20, 2026
BarclaysUnderweight$20Oct 7, 2026
CitigroupNeutral$28Jul 31, 2026

Questions about Morgan Stanley and BAX

What is Morgan Stanley's price target for BAX?
Morgan Stanley's latest stated price target for Baxter International Inc. (BAX) is $30, from its action on Jul 15, 2024.
What is Morgan Stanley's rating on BAX?
Morgan Stanley rates BAX Underweight, a bearish rating, as of Jul 15, 2024.
When did Morgan Stanley last change its view on BAX?
On Jul 15, 2024, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $39 to $30.

More BAX rating histories

All Morgan Stanley ratingsBAX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.